Wednesday, June 17, 2026 The gateway for independent voices — journalism, podcasts & documentaries
RSS
Established for Independent Voices
IJNN.World
Independent Journalist News Network


Breaking
— Archion (TSE:543A) Stock Price Looks Close To Fair Value After Recent Reassessment — Uconn Health Assistant Nursing Manager – Neonatal Intensive Care Unit in Farmington, CT — Country Star Announces Update on North America Tour — National League Team Statistics — Lockton appoints Stéphane Lespérance as CEO of its Canadian Business — Archion (TSE:543A) Stock Price Looks Close To Fair Value After Recent Reassessment — Uconn Health Assistant Nursing Manager – Neonatal Intensive Care Unit in Farmington, CT — Country Star Announces Update on North America Tour — National League Team Statistics — Lockton appoints Stéphane Lespérance as CEO of its Canadian Business

Uncategorized

Archion (TSE:543A) Stock Price Looks Close To Fair Value After Recent Reassessment

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. • If you are wondering whether ARCHION stock is starting to look interesting at its current price, the key question is how that price compares with a fair estimate of value. • The share price […]

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
• If you are wondering whether ARCHION stock is starting to look interesting at its current price, the key question is how that price compares with a fair estimate of value.
• The share price last closed at ¥299, with returns that declined 0.3% over the past week, 18.1% over the past month, 24.9% year to date, and 22.2% over the past year, which frames how the market has been reassessing the company over time.
• Recent coverage of ARCHION has focused on its longer term performance record and how the market has responded, which helps explain why some investors are reassessing the risk and reward trade off. This context is useful when thinking about whether the current price level reflects an opportunity or simply ongoing caution.
• On Simply Wall St’s checks, ARCHION currently has a valuation score of 3 out of 6. The sections that follow will compare different valuation methods before returning to an even broader way to think about what the stock might be worth. Find out why ARCHION’s -22.2% return over the last year is lagging behind its peers. A Discounted Cash Flow, or DCF, model estimates what ARCHION stock might be worth by projecting future cash flows and then discounting them back to today using a required return. It is essentially asking what a stream of future cash in ¥ is worth in current terms. For ARCHION, the latest twelve month free cash flow is reported at ¥9,209.05 million, based on a 2 Stage Free Cash Flow to Equity model. Analyst input is available for several years, with a forecast free cash flow of ¥45,000 million in the year ending 31 March 2029. Beyond the explicit analyst period, Simply Wall St extends the projections, with ten year estimates ranging from ¥87,000 million in 2026 to around ¥50,555.34 million by 2035, using a mix of analyst data and gradual extrapolation. Discounting these projected cash flows back to today gives an estimated intrinsic value of ¥286.06 per share. Compared to the recent share price of ¥299, the DCF output suggests ARCHION is about 4.5% above this estimate, which is a relatively small gap in valuation terms. ARCHION is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment’s notice. Track the value in your watchlist or portfolio and be alerted on when to act. Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for ARCHION.

For a profitable company like ARCHION, the P/E ratio is a straightforward way to think about valuation because it links the share price to the earnings that support it. In general, higher growth expectations or lower perceived risk can justify a higher P/E, while lower growth or higher risk can point to a lower, more cautious multiple. ARCHION currently trades on a P/E of 9.77x. This sits below the Machinery industry average P/E of 14.40x and also below the peer group average of 13.08x. On the surface, this suggests the stock is priced more conservatively than many industry peers. Simply Wall St also provides a proprietary “Fair Ratio” for ARCHION of 21.19x. This is the P/E level that might be expected after accounting for factors such as the company’s earnings profile, its industry, profit margins, market capitalization and risk characteristics. Because the Fair Ratio is tailored to ARCHION, it goes further than simple comparisons with peer or industry averages, which do not adjust for company specific strengths or risks. Comparing the current P/E of 9.77x with the Fair Ratio of 21.19x indicates ARCHION stock screens as undervalued on this metric. P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 11 top founder-led companies. Earlier it was mentioned that there is an even better way to understand valuation, so this is where Narratives come in for ARCHION stock. A Narrative is simply your story about ARCHION, where you set your own view of fair value and your estimates for future revenue, earnings and margins, then link that story to a financial forecast and finally to a fair value per share. On Simply Wall St, Narratives are available on the Community page and are designed to be easy to use, so you can focus on what you believe rather than on building complex models. Narratives help you frame whether you want to buy, hold or sell by constantly comparing your Fair Value with the current market price and updating that view when new information such as news or earnings is released. For example, one ARCHION Narrative might assume a very cautious fair value and another a much higher fair value based on different expectations for future profitability. This shows how investors can look at the same stock and reach different, clearly quantified conclusions. Do you think there’s more to the story for ARCHION? Head over to our Community to see what others are saying! This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com…Read more by Bailey Pemberton

‹ Uconn Health Assistant Nursing Manager -…